International Journal of Advanced Biochemistry Research

Biochem
Journal

Printed Journal   |   Indexed Journal   |   Refereed Journal   |   Peer Reviewed Journal

Vol. 8, Special Issue 2, Part F (2024)

Virological and molecular characterization of canine distemper virus passaged at high temperature towards development of thermostable vaccine candidate

Author(s): Chris Einstien, KK Rajak, Mukesh Bhatt, Ajay Kumar Yadav, Vishal Rai, Monu Karki, Ashok Kumar, Kiran, Ravi Thakur, Aneppu Revathi, Harsh Rajeshbhai Jogi and RP Singh
Abstract: Thermolabile nature of viruses is a major problem faced by most live attenuated vaccines. Addressing this issue will help increase the success rate of vaccination and reduce the economic burden on vaccination campaigns. In current study, the Canine Distemper Virus (CDV) belonging to India-1/Asia-5 lineage was adapted to grow at 41.5 °C for assessing its suitability as thermostable vaccine candidate. The growth kinetics of thermotolerant virus was compared to that of original parent virus and it was found that the thermotolerant virus could grow only to a lower titre (3.01 logTCID50 per ml) in Vero cells as compared to the parent virus (5.26 logTCID50 per ml). When the coding sequences of structural genes of the virus M, N, H and F were compared before and after the high temperature passage, it was found that the F gene accrued the highest number of changes as compared to other genes of CDV. The mapped mutations in DNA and substitutions in amino acid sequences may shed light on the structural and functional mechanisms of virus adaptation at high temperature to be used as a strategy for creating recombinant thermostable vaccines.
Pages: 402-409  |  300 Views  161 Downloads
How to cite this article:
Chris Einstien, KK Rajak, Mukesh Bhatt, Ajay Kumar Yadav, Vishal Rai, Monu Karki, Ashok Kumar, Kiran, Ravi Thakur, Aneppu Revathi, Harsh Rajeshbhai Jogi, RP Singh. Virological and molecular characterization of canine distemper virus passaged at high temperature towards development of thermostable vaccine candidate. Int J Adv Biochem Res 2024;8(2S):402-409. DOI: 10.33545/26174693.2024.v8.i2Sf.602
International Journal of Advanced Biochemistry Research
Call for book chapter